Prodia StemCell Indonesia Report issue

For profit Phase 2
Founded: jakarta Indonesia (1973)

Organization Overview

First Clinical Trial
2018
NCT04357600
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Prodia Stem Cell Indonesia | Prodia StemCell Indonesia | PT. Prodia Stem Cell Indonesia